Pharma BD Deal Intelligence

Globus Medical, Inc. / Nevro Corp.

2025 · Acquisition/Merger · $250M · Pending

Globus Medical and Nevro Corp. announced a definitive agreement on February 6, 2025 for Globus Medical to acquire all shares of Nevro in an all-cash transaction at $5.85 per share, representing a total equity value of approximately $250 million. The transaction was unanimously approved by both boards and gives Globus access to Nevro's spinal cord stimulation and neuromodulation platform for chronic pain, expanding Globus beyond its musculoskeletal core. Status recorded as of the announcement; closing was subject to Nevro stockholder approval and regulatory clearance - close date not verified in this backfill pass.

This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2030 at the earliest for this deal, once/if it closes.

Key facts

Related deals

See the full interactive analysis, sources & comparables →

← Browse all deals  ·  How we score deals

More: 2025 deals